Skip to main content

Envisioning is an emerging technology research institute and advisory.

LinkedInInstagramGitHub

2011 — 2026

research
  • Reports
  • Newsletter
  • Methodology
  • Origins
  • My Collection
services
  • Research Sessions
  • Signals Workspace
  • Bespoke Projects
  • Use Cases
  • Signal Scanfree
  • Readinessfree
impact
  • ANBIMAFuture of Brazilian Capital Markets
  • IEEECharting the Energy Transition
  • Horizon 2045Future of Human and Planetary Security
  • WKOTechnology Scanning for Austria
audiences
  • Innovation
  • Strategy
  • Consultants
  • Foresight
  • Associations
  • Governments
resources
  • Pricing
  • Partners
  • How We Work
  • Data Visualization
  • Multi-Model Method
  • FAQ
  • Security & Privacy
about
  • Manifesto
  • Community
  • Events
  • Support
  • Contact
  • Login
ResearchServicesPricingPartnersAbout
ResearchServicesPricingPartnersAbout
Virtual Exposure Protocols | Impulse | Envisioning
  1. Home
  2. Research
  3. Impulse
  4. Virtual Exposure Protocols

Virtual Exposure Protocols

Simulations for desensitization therapy.
BACK TO IMPULSE

Related Organizations

Amelia Virtual Care logo
Amelia Virtual Care

ES · Company

95%

A leading VR platform for mental health professionals, offering a library of virtual environments for exposure therapy (phobias, anxiety).

Developer
USC Institute for Creative Technologies logo
USC Institute for Creative Technologies

US · University

95%

Home to the 'Bravemind' project, a clinical VR exposure therapy tool for treating PTSD in veterans.

Researcher
AppliedVR logo
AppliedVR

Supporting Evidence

Evidence data is not available for this technology yet.

Same technology in other hubs

Soma
Soma
Therapeutic VR Exposure

Immersive environments for treating PTSD and anxiety.

Connections

Explore this signal in your context

Get a focused view of implications, timing, and action options for your organization.
Discuss this signal
VIEW INTERACTIVE VERSION

US · Company

90%

Creators of RelieVRx, an FDA-authorized VR therapeutic for chronic lower back pain.

Developer
Veterans Health Administration logo
Veterans Health Administration

US · Government Agency

90%

The largest integrated health care system in the US, actively deploying VR exposure therapy (Bravemind) for veterans with PTSD.

Deployer
Virtually Better logo
Virtually Better

US · Company

90%

One of the earliest pioneers in VR exposure therapy, providing systems for treating fear of flying, heights, and public speaking.

Developer
C2Care logo
C2Care

FR · Company

85%

French company developing therapeutic VR software for phobias, addictions, and anxiety disorders.

Developer
Limbix logo
Limbix

US · Company

85%

Developed SparkRx, a digital therapeutic program for adolescent depression based on CBT principles.

Developer
XRHealth logo
XRHealth

US · Company

85%

Operates virtual clinics providing VR therapy for various conditions.

Developer
Khora logo
Khora

DK · Company

80%

Scandinavian VR/AR production studio creating immersive art installations and theater experiences.

Developer
OVR Technology logo
OVR Technology

US · Startup

80%

Creates wearable scent technology (ION) for VR/AR headsets to deliver precise olfactory experiences.

Developer
Applications
Applications
Digital Satiation Therapies

VR/AR simulating consumption to manage cravings.

TRL
5/9
Impact
4/5
Investment
3/5
Software
Software
Adaptive Stimuli Generators

Dynamic A/V adjustment based on neurofeedback.

TRL
6/9
Impact
3/5
Investment
4/5

Virtual Exposure Protocols represent a sophisticated application of immersive technology in clinical psychology, leveraging high-fidelity virtual reality systems to create controlled therapeutic environments for treating anxiety-based disorders. These protocols utilize head-mounted displays, spatial audio systems, and sometimes haptic feedback devices to generate realistic simulations of anxiety-provoking scenarios—from crowded public spaces and heights to combat situations and social interactions. The technology operates on the principle of graduated exposure, where clinicians can precisely calibrate the intensity, duration, and complexity of virtual stimuli, allowing for systematic desensitization that follows established therapeutic frameworks. Unlike traditional exposure therapy, which relies on imagination-based techniques or real-world exposure that can be difficult to control or reproduce consistently, virtual protocols offer repeatable, scalable scenarios that can be paused, adjusted, or repeated as needed. The systems typically include biometric monitoring capabilities that track physiological responses such as heart rate variability and galvanic skin response, providing clinicians with objective data to inform treatment progression and ensure patient safety throughout the therapeutic process.

The clinical challenges these protocols address are substantial, particularly in treating conditions where traditional exposure therapy faces practical or ethical limitations. For patients with severe PTSD, recreating trauma-related environments in the real world may be impossible, prohibitively expensive, or potentially harmful if not carefully controlled. Similarly, phobia treatment often requires access to specific stimuli—such as flying, spiders, or medical procedures—that cannot be readily summoned on demand in a clinical setting. Virtual Exposure Protocols solve these problems by providing on-demand access to any conceivable scenario while maintaining complete therapeutic control. This technology also addresses the significant dropout rates associated with traditional exposure therapy, as patients often find virtual environments less overwhelming than immediate real-world exposure, improving treatment adherence. The economic implications are equally significant, as these protocols can reduce the need for costly field trips, specialized equipment, or the coordination of complex real-world scenarios, making evidence-based exposure therapy more accessible to a broader range of clinical settings and patient populations.

Research institutions and clinical practices have begun integrating these protocols into standard treatment regimens, with early deployments indicating promising outcomes for conditions ranging from social anxiety disorder to specific phobias and combat-related PTSD. Veterans' health systems have been particularly active in adopting virtual exposure therapy for treating service-related trauma, while anxiety disorder clinics are employing the technology for everything from fear of public speaking to agoraphobia. The protocols are increasingly being combined with other therapeutic modalities, such as cognitive-behavioral therapy and mindfulness techniques, creating integrated treatment approaches that leverage the unique capabilities of immersive technology. As virtual reality hardware becomes more affordable and accessible, and as clinical evidence continues to accumulate, these protocols are positioned to become a standard component of mental health treatment infrastructure. The trajectory points toward increasingly personalized therapeutic experiences, where artificial intelligence may eventually help tailor virtual scenarios to individual patient responses in real-time, and where remote therapy delivery could extend specialized treatment to underserved populations, fundamentally expanding access to evidence-based mental health interventions.

TRL
8/9Deployed
Impact
5/5
Investment
4/5
Category
Applications

Newsletter

Follow us for weekly foresight in your inbox.

Browse the latest from Artificial Insights, our opinionated weekly briefing exploring the transition toward AGI.
Mar 8, 2026 · Issue 131
Mar 8, 2026 · Issue 131
Prompt it into existence
Feb 23, 2026 · Issue 130
Feb 23, 2026 · Issue 130
An Apocaloptimist
Feb 9, 2026 · Issue 129
Feb 9, 2026 · Issue 129
Agent in the Loop
View all issues